Patents
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
05/2010
05/04/2010CA2281920C Compositions and methods for modulating cellular nf-.kappa.b activation
04/2010
04/29/2010WO2010048306A1 High-throughput assay for evaluating dipeptidyl peptidase i activity
04/29/2010WO2010047515A2 Bipodal peptide binder
04/29/2010WO2010047310A1 Tumor antigen peptide and use thereof
04/29/2010WO2010046900A2 Rgd-containing peptidomimetics and uses thereof
04/29/2010WO2010046628A1 Compounds
04/29/2010WO2010046588A1 Peptide derivatives and use thereof as carriers for molecules in the form of conjugates
04/29/2010WO2010011994A3 Polypeptides and uses thereof
04/29/2010WO2010009227A3 Recombinant pokeweed antiviral proteins, compositions and methods related thereto
04/29/2010WO2009109156A3 Novel antimicrobial peptides and their application
04/29/2010US20100105626 Novel Analogues of Antimicrobial and Anticancer Peptide Synthesized and Produced from Gaegurin 5
04/29/2010US20100105625 Product and Methods for Diagnosis and Therapy for Cardiac and Skeletal Muscle Disorders
04/29/2010US20100105620 Polypeptides that bind Trail-R1 and Trail-R2
04/29/2010US20100105619 Cysteine-containing peptides having antioxidant properties
04/29/2010US20100105609 Processes for Preparing Eptifibatide
04/29/2010US20100105567 Novel capture agents for binding a ligand
04/29/2010US20100104607 Anti-bacterial peptides and methods of treating diseases using same
04/29/2010US20100104606 Allergen fragments
04/29/2010US20100104576 Polypeptide fusion comprising three nonoverlapping domains for use as tool in identifying modulator for enhancing immune response; immunization;
04/29/2010US20100104521 Cosmetic and/or pharmaceutical composition comprising as an active principle at least one peptide and use of this peptide
04/29/2010CA2741207A1 Rgd-containing peptidomimetics and uses thereof
04/29/2010CA2741190A1 High-throughput assay for evaluating dipeptidyl peptidase i activity
04/29/2010CA2741098A1 Peptide derivatives and use thereof as carriers for molecules in the form of conjugates
04/29/2010CA2741040A1 Bipodal-peptide binder
04/28/2010EP2180054A1 Methods and compositions for prolonging elimination half-times of bioactive compounds
04/28/2010EP2178551A1 Novel peptides with anti-tumor activity
04/28/2010EP1664332B1 Kinase and phosphatase assays
04/28/2010CN1972957B Potassium channel regulating pepetide
04/28/2010CN1688600B Template-fixed peptidomimetics with antibacterial activity
04/28/2010CN1596266B Specific binding agents of human angiopoietin-2
04/27/2010USRE41287 Cyclic agonists and antagonists of C5A receptors and G Protein-coupled receptors
04/27/2010US7705119 A Deltorphin-E polypeptide having a specific amino acid sequence and acarrier; antishock agents; opiod receptor agonists; nucleotide sequence;hypertensive agents; antiinflammatory agents; antiischemic agents; surgery;restoring perfusion to organs and tissues; prophylaxis
04/27/2010US7705012 7-iminomethyl or 7-oxymethyl camptothecin derivatives conjugated, possibly by means of suitable spacers, to cyclopeptide derivatives containing the arginine-glycine-aspartic acid sequence; anticarcinogenic, antimetastasis agent; high affinity for integrin receptors alpha v beta 3 and alpha v beta 5
04/27/2010US7704969 Transfection complexes
04/27/2010US7704955 polypeptide which can be used to treat, prevent, and modulate pain, inflammation, and metabolic processes in various organisms including plants and animals
04/27/2010US7704947 Methods and compositions for the treatment of gastrointestinal disorders
04/27/2010US7704512 Light chain that cleaves a neurosecretory protein; an HN domain that translocates the light chain across an endosome membrane and a substance P targeting moiety; the HC domain is removed or modified to reduce the targeting of the modified Clostridial toxin to the neuromuscular junction
04/27/2010CA2293692C Methods and reagents for vaccination which generate a cd8 t cell immune response
04/27/2010CA2203758C Compositions for the detection of proteases in biological samples and methods of use thereof
04/22/2010WO2010045586A2 Muc-1 cytoplasmic domain peptides as inhibitors of cancer
04/22/2010WO2010045469A2 Muc18 targeting peptides
04/22/2010WO2010045342A1 Method of making biologically active alpha-beta peptides
04/22/2010WO2010044786A1 Modified variant bowman birk protease inhibitors
04/22/2010WO2010043049A1 Etoposide and doxorubicin conjugates for drug delivery
04/22/2010WO2010043039A1 Combination adjuvant formulation
04/22/2010WO2009151714A3 Therapeutic for treatment of circulatory shock, ischemia, inflammatory disease and related conditions
04/22/2010WO2009149278A8 Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
04/22/2010WO2009027706A3 Radiolabeled monomeric and multimeric cyclic oligopeptides binding to the cxcr4 receptor for cancer imaging and treatment
04/22/2010US20100099845 Protected enantiopure trifluorothreonines and methods of making and using same
04/22/2010US20100099843 Dolastatin 15 derivatives
04/22/2010US20100099786 Carbamate, thiocarbamate or carbamide comprising a biomolecular moiety
04/22/2010US20100099629 Ophthalmological composition
04/22/2010US20100099627 Nuclear targeting sequences
04/22/2010US20100099604 Peptidic and non peptidic ligands for immunodetection of the receptor for urotensin
04/22/2010US20100099121 Method for the diagnosis of cancers by measuring the changes of glycosylation of proteins related to tumorigenesis and metastasis and kit for diagnosis of cancers using the same
04/22/2010US20100099113 Minimized small peptides with high affinity for factor viii and factor viii-like proteins
04/22/2010US20100098748 Arg-Gly-Asp (RGD) Sequence Containing Cyclic Peptide and Its Active Targeting Liposomes
04/22/2010US20100098717 Polypeptides Recognized by Anti-Trichinella Antibodies, and Uses Thereof
04/22/2010US20100098683 MUC1 and Galectin-3
04/22/2010US20100098671 composition for prevention or treatment of bone marrow damage
04/22/2010DE102005049537B4 Verfahren zur Herstellung zyklischer Peptide und Verwendung der derart hergestellten zyklischen Peptide Process for the preparation of cyclic peptides and cyclic peptides using the thus produced
04/22/2010CA2741065A1 Muc-1 cytoplasmic domain peptides as inhibitors of cancer
04/22/2010CA2740873A1 Method of making biologically active alpha-beta peptides
04/22/2010CA2740317A1 Etoposide and doxorubicin conjugates for drug delivery
04/22/2010CA2740197A1 Modified variant bowman birk protease inhibitors
04/22/2010CA2737352A1 Combination adjuvant formulation
04/21/2010EP2177534A2 Heteroclitic analogs of class i epitopes
04/21/2010EP2177531A2 Cell permeable peptide
04/21/2010EP2177530A1 Octapeptide having antiangiogenic activity
04/21/2010EP1635692B1 Monitoring immunologic, hematologic and inflammatory diseases
04/21/2010EP1519945B1 Novel chemokine binding peptides capable of modulating the biological activity of chemokines
04/21/2010EP1323730B1 Novel polypeptides and anti-hiv drugs containing the same
04/21/2010CN1978462B Imidazoline modified amino acid, and its synthesizing method and use for polypeptide marking
04/21/2010CN1763084B High purity cyclosporin A preparation method
04/21/2010CN101696399A Porcine reproductive and respiratory syndrome virus M protein CTL cell epitopes and application thereof
04/21/2010CN101696236A Method for synthesizing atosiban by solid phase
04/21/2010CN101696235A Daptomycin analog and full solid phase synthesis preparation method thereof
04/21/2010CN101696234A Polypeptide for resisting rheumatoid arthritis and application thereof in pharmacy
04/21/2010CN101696233A Albumin angiotensin converting enzyme inhibition peptide and preparation method thereof
04/21/2010CN101696232A Peptidomimetic protease inhibitors
04/21/2010CN101696231A Antigen epitope minimum motif peptide of human papilloma virus 58 type E6 protein
04/21/2010CA2641448A1 Synthetic antigen mimetics matrices immuno-reactive with rheumatoid arthritis auto-antibodies
04/20/2010USRE41252 Peptidyl prodrugs and linkers and stabilizers useful therefor
04/20/2010US7700755 cytotoxins; host cells; vaccines; histology
04/20/2010US7700721 antiparallel peptide arrangement; self-assembling; bone repair
04/20/2010US7700716 Polytetrafluoroethylene binding peptides and methods of use
04/20/2010US7700559 Gonadotropin releasing hormone analogues conjugates with steroid hormones
04/20/2010US7700544 Compositions and methods for treating atherosclerosis
04/20/2010US7700109 Biomolecule transduction motif Mph-1-BTM and the use thereof
04/20/2010US7700087 Compounds and methods to inhibit or augment an inflammatory response
04/20/2010CA2417207C Dental products comprising bone growth enhancing peptide
04/15/2010WO2010042890A2 Polypeptides that bind trail-ri and trail-r2
04/15/2010WO2010042548A2 Methods of treating inflammation
04/15/2010WO2010041241A2 Hiv-1 integrase derived peptides and compositions
04/15/2010WO2010040209A1 Methods and systems for predicting misfolded protein epitopes
04/15/2010WO2010015287A3 Template-fixed peptidomimetics
04/15/2010WO2009135118A9 Lyme disease vaccine
04/15/2010WO2009006246A8 Use of tight junction antagonists in the treatment of acute long injury and acute respiratory distress syndrome
04/15/2010US20100095390 Aldolases, Nucleic Acids Encoding Them and Methods for Making and Using Them
04/15/2010US20100093975 Used for peptide synthesis